• Science & Technology

Cancer Research UK and Lilly collaborate to trial combinations of potential new cancer treatments

Cancer Research UK's Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer. Cancer Research UK's Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.

17 December 2013

• Science & Technology

Nearly all men survive testicular cancer

Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease latest figures show. Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease latest figures show.

29 July 2013

• Science & Technology

Researchers exploit cancer’s faulty defence mechanism

Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments. Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.

12 June 2013

• Science & Technology
• Health & Medicine

'Treatment alliance' needed to save more children's lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children. Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

6 October 2012

• Science & Technology

Diabetes treatment doubles skin cancer drug's effectiveness

Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery. Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.

31 March 2012

• Science & Technology

Scientists find new drug target for hard-to-treat leukaemia

Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia. Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia.

29 March 2012

• Science & Technology

Cancer Research Technology appoints new chairman to its board of directors

Cancer Research Technology - the commercial arm of Cancer Research UK - today announced the appointment of Peter Chambrй as its new chairman. Cancer Research Technology - the commercial arm of Cancer Research UK - today announced the appointment of Peter Chambrй as its new chairman.

13 October 2011

• Science & Technology

Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing

Senectus Therapeutics has signed a deal to screen a selection of AstraZenecaїs chemical compound library to identify those which trigger a key element of cancer cell ageing ї called senescence. Senectus Therapeutics has signed a deal to screen a selection of AstraZenecaїs chemical compound library to identify those which trigger a key element of cancer cell ageing ї called senescence.

23 March 2011

• Science & Technology
• Health & Medicine

Powerful online cancer drug discovery database unveiled

A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'. A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'.

29 November 2010

• Health & Medicine
• Science & Technology

Cancer Research UK and immatics biotechnologies launch trial for brain cancer

Cancer Research UK and Cancer Research Technology with immatics biotechnologies have launched the first trial of a promising cancer vaccine. Cancer Research UK and Cancer Research Technology with immatics biotechnologies have launched the first trial of a promising cancer vaccine.

19 October 2010

• Science & Technology
• Health & Medicine

Cancer Research UK and AstraZeneca sign deal to trial first-of-kind cancer drug

Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to potentially treat a range of cancers into clinical trial. Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug to potentially treat a range of cancers into clinical trial.

13 September 2010

• Science & Technology

CRT and Bayer Schering Pharma to investigate new therapeutic approach in gynaecological and oncological diseases

CANCER RESEARCH TECHNOLOGY has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer. CANCER RESEARCH TECHNOLOGY has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.

25 August 2010